Journal of Diabetes Research / 2016 / Article / Tab 2

Research Article

Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections

Table 2

Oxidative stress and inflammatory profile of newly diagnosed and long-standing T2DM patients.

CSII N groupMDI3 N groupMDI4 N group

8-PGF (pg/mL)
 N
  Before therapy8.11 ± 2.779.46 ± 0.8910.15 ± 2.34
  After therapy6.12 ± 2.667.00 ± 1.936.70 ± 2.53
 L
  Before therapy8.07 ± 2.898.58 ± 3.148.46 ± 1.75
  After therapy4.10 ± 2.935.17 ± 3.884.16 ± 2.10
TNF-α (pg/mL)
 N
  Before therapy19.59 ± 4.5618.01 ± 7.4117.11 ± 6.32
  After therapy9.08 ± 5.1410.26 ± 3.338.12 ± 5.00
 L
  Before therapy13.46 ± 2.9914.53 ± 3.2311.65 ± 4.58
  After therapy6.08 ± 1.148.70 ± 2.346.25 ± 2.37
IL-6 (pg/mL)
 N
  Before therapy4.51 ± 1.875.08 ± 1.126.08 ± 4.52
  After therapy2.17 ± 1.432.60 ± 0.782.90 ± 1.84
 L
  Before therapy3.66 ± 2.194.12 ± 1.883.73 ± 2.00
  After therapy2.62 ± 2.164.32 ± 1.453.01 ± 2.55

Data are mean ± (SD). , versus the same item before therapy; versus MDI3 N group after therapy. N: newly diagnosed T2DM patients group; L: long-standing T2DM patients group.